Alexion Pharma (ALXN) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Net product sales: 752.55M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net product sales: 752.55M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) reported Q1 EPS of $1.11, $0.02 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $701 million versus the consensus estimate of $710.98 million.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
